Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Klinik for Fysioterapi Rødding/Gram Aps. Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.2% 6.4% 6.9% 4.6% 11.2% 4.2% 17.4% 17.4%   Credit score (0-100)   67 38 35 45 21 47 9 9   Credit rating   BBB BBB BBB BBB BB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,056 961 843 1,278 1,758 1,948 0.0 0.0   EBITDA   288 127 11.1 334 511 977 0.0 0.0   EBIT   200 93.3 -22.7 300 484 977 0.0 0.0   Pre-tax profit (PTP)   174.8 95.9 48.8 308.7 509.7 1,001.1 0.0 0.0   Net earnings   136.3 75.6 48.3 240.7 397.3 780.4 0.0 0.0   Pre-tax profit without non-rec. items   175 95.9 48.8 309 510 1,001 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,808 70.8 11.4 2.1 0.0 0.0 0.0 0.0   Shareholders equity total   1,077 221 199 395 552 1,083 243 243   Interest-bearing liabilities   1,949 1.1 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,202 364 476 800 836 1,491 243 243   Net Debt   1,810 -54.0 -102 -381 -49.1 -74.3 -243 -243     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,056 961 843 1,278 1,758 1,948 0.0 0.0   Gross profit growth   2.3% -9.0% -12.3% 51.6% 37.5% 10.8% -100.0% 0.0%   Employees   2 2 2 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 50.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,202 364 476 800 836 1,491 243 243   Balance sheet change%   1.6% -88.6% 30.8% 68.2% 4.5% 78.4% -83.7% 0.0%   Added value   287.9 127.1 11.1 333.5 517.8 977.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -175 -2,795 -118 -68 -53 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.0% 9.7% -2.7% 23.5% 27.5% 50.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.4% 5.6% 12.8% 49.6% 62.8% 86.5% 0.0% 0.0%   ROI %   6.6% 6.1% 24.3% 103.1% 107.8% 123.1% 0.0% 0.0%   ROE %   13.0% 11.6% 23.0% 81.0% 83.9% 95.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   33.6% 60.7% 41.9% 49.4% 66.1% 72.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   628.9% -42.5% -923.9% -114.3% -9.6% -7.6% 0.0% 0.0%   Gearing %   181.0% 0.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.4% 0.3% 940.6% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.6 1.6 1.9 2.9 3.7 0.0 0.0   Current Ratio   1.3 1.6 1.6 1.9 2.9 3.7 0.0 0.0   Cash and cash equivalent   138.1 55.0 102.5 381.1 49.1 74.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   66.8 85.7 152.2 374.2 552.2 1,082.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   144 64 6 111 173 326 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   144 64 6 111 170 326 0 0   EBIT / employee   100 47 -11 100 161 326 0 0   Net earnings / employee   68 38 24 80 132 260 0 0